ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.
Aktien
A1J68D
CNE100001M79
2196
Pharmazeutika
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
12.32 HKD | -0.48% | +4.76% | -27.53% |
10:58 | Gewinn von Fosun Pharma bricht in Q1 um 38% ein | MT |
29.04. | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 | CI |
ETFs investiert in Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
2,37% | 4 M€ | -27.92% | ||
0,63% | 2 M€ | -14.86% | - | |
0,21% | 3 M€ | +0.62% | - | |
0,18% | 2 M€ | -14.14% | ||
0,16% | 4 M€ | -11.56% | ||
0,03% | 35 M€ | -5.85% | - | |
0,02% | 441 M€ | +5.00% | - | |
0,02% | 2 808 M€ | +6.31% | - | |
0,02% | 149 M€ | +3.21% | - | |
0,02% | 4 M€ | -4.41% | - | |
0,01% | 31 M€ | +4.15% | - | |
0,01% | 117 M€ | +1.01% | - | |
0,00% | 34 M€ | +6.75% | - | |
0,00% | 34 M€ | +2.43% | - | |
0,00% | 39 M€ | +4.26% | - | |
0,00% | 302 M€ | +4.26% | - | |
0,00% | 147 M€ | +4.88% | - | |
0,00% | 7 M€ | +0.11% | - | |
0,00% | 17 M€ | +1.67% | - | |
0,00% | 15 M€ | +13.33% | ||
0,00% | 7 M€ | +2.17% | - | |
0,00% | 8 M€ | -0.23% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+35.40% | 664 Mrd. | |
+29.65% | 567 Mrd. | |
-7.22% | 354 Mrd. | |
+19.48% | 330 Mrd. | |
+4.49% | 286 Mrd. | |
+13.43% | 234 Mrd. | |
+5.23% | 199 Mrd. | |
-9.98% | 196 Mrd. | |
-4.68% | 148 Mrd. |
- Börse
- Aktien
- A0M5XT Aktie
- A1J68D Aktie
- ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.